Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.5%

98 terminated/withdrawn out of 1036 trials

Success Rate

86.9%

+0.4% vs industry average

Late-Stage Pipeline

71 trials in Phase 3/4

Results Transparency

23%

153 of 652 completed trials have results

Key Signals

144 recruiting153 with results58 terminated40 withdrawn

Enrollment Performance

Analytics

N/A

609(70.2%)

Phase 1

94(10.8%)

Phase 2

71(8.2%)

Phase 4

47(5.4%)

Phase 3

24(2.8%)

Early Phase 1

22(2.5%)

867Total

N/A(609)

Phase 1(94)

Phase 2(71)

Phase 4(47)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1036)

Showing 20 of 1036 trials

NCT07737873Recruiting

Examining Relationships Between Musculoskeletal Function Measurements of Movement Efficiency and Nervous System Function After Chronic Stroke

Role: lead

NCT07734948Not ApplicableNot Yet Recruiting

Cardiovascular Effects of Purple-Fleshed Potatoes

Role: collaborator

NCT07717723Not ApplicableRecruiting

Supporting Mental Health and Reducing Care Stress in Caregivers of Persons With Cardiovascular Disease

Role: lead

NCT03629197Not ApplicableCompleted

Improving Communication About Pain and Opioids

Role: lead

NCT05586776Phase 4Recruiting

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

Role: collaborator

NCT05052528Phase 1Recruiting

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Role: lead

NCT07108452Not ApplicableNot Yet Recruiting

Using an AI Mobile Application to Promote Healthy Eating

Role: lead

NCT07322133Phase 4Recruiting

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

Role: lead

NCT06831929Not ApplicableActive Not Recruiting

HPV Ends Here: Increasing Uptake of the HPV Vaccine

Role: lead

NCT06237127Not ApplicableRecruiting

Effects of Goji vs. Fiber on Macular Degeneration

Role: lead

NCT06016634Phase 2Recruiting

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Role: lead

NCT05843448Phase 1Active Not Recruiting

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Role: lead

NCT07189195Phase 1Recruiting

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Role: lead

NCT07443839Not ApplicableCompleted

Oncology Legal Navigation Study

Role: collaborator

NCT07397858Not ApplicableRecruiting

Cognition and Behavior With Sham Accelerated TMS

Role: lead

NCT05701657Not ApplicableRecruiting

Nutrition for Precision Health, Powered by the All of Us